New Issue: Biomoda pockets $1 million through private placement of common stock

By Devika Patel

Knoxville, Tenn., March 19 - Biomoda, Inc. completed a $1 million private placement of stock, according to an 8-K filed Friday with the Securities and Exchange Commission. The deal priced March 17. LifeTech Capital, Inc. was the agent.

The company sold 6,250,001 common shares at $0.16 per share.

Investors also received series I warrants for 6,250,001 shares, series II warrants for 3,750,001 shares and series III warrants for 6,250,001 shares. The five-year series I warrants are exercisable at $0.25 apiece. The series II warrants are exercisable at $0.01 per share. The 60-day series III warrants are exercisable at $0.16 per share.

The cancer diagnostics company is based in Albuquerque, N.M.

Issuer:	Biomoda, Inc.
Issue:	Common stock
Amount:	$1 million
Shares:	6,250,001
Price:	$0.16
Warrants:	For 16,250,003 shares
Warrant expiration:	Five years (for 6,250,001 shares), 60 days (for 6,250,001 shares)
Warrant strike price:	$0.25 (for 6,250,001 shares), $0.01 (for 3,750,001 shares), $0.16 (for 6,250,001 shares)
Agent:	LifeTech Capital, Inc.
Pricing date:	March 17
Stock symbol:	OTCBB: BMOD
Stock price:	$0.22 at close March 17
Market capitalization:	$16.2 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.